A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And ...
Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.
Seeking Alpha on MSN13h
Novo's Rybelsus results may not be clinically meaningful, Bernstein saysBernstein said Novo Nordisk (NVO) study results that showed certain Rybelsus users had a 14% risk reduction for major ...
WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...
New guidelines from the AHA and ASA recommend GLP-1 drugs like Ozempic and Wegovy for stroke prevention in patients with ...
SURVEY SAYS: Just 18% of the health-care plans sponsored by employers with 200 workers or more cover such drugs, according to ...
Earlier this month, WeightWatchers made the extraordinary announcement that it would be offering its own version of the 'fat ...
Viatris Inc.'s volatile stock performance, CEO's strategic focus on growth, and promising pipeline highlight potential for ...
Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today joined President Joe Biden in Concord, New Hampshire at the New Hampshire Technical Institute for an event on ...
Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...
Navy Times on MSN20h
Weighing benefits: Could anti-obesity meds help troops’ weight issues?Advocates argue that anti-obesity drugs like Ozempic could help overweight troops, but the services have no uniform policy ...
Zacks.com on MSN16h
NVO's Rybelsus Meets Primary Goal in MACE Study for Diabetes PatientsNovo Nordisk NVO announced positive top-line data from a late-stage cardiovascular outcomes study that evaluated its oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback